Artificial Intelligence (AI) has become one of the most talked-about innovations in clinical research, driving advances in everything from patient recruitment to data analysis. The field is now evolving further with the rise of agentic AI—systems…
Making clinical trials more diverse isn’t just the right thing to do — it’s essential for developing treatments that work for everyone. Yet, despite FDA guidance, many trials still fail to reflect the real-world diversity of…
In the year 2000, ClinicalTrials.gov was launched with just 1,255 clinical trials listed. Fast-forward to today, and that number has grown to over 520,000, reflecting not only the acceleration of biomedical research but also the growing…
Bringing a new treatment or drug to market remains a time-consuming and expensive process, often taking over a decade and costing billions of dollars. Despite the best efforts of researchers, more than 80% of clinical trials…